Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Shenzhen - Delayed Quote CNY

Tianjin Lisheng Pharmaceutical Co.,Ltd. (002393.SZ)

Compare
17.08
-0.02
(-0.12%)
At close: February 21 at 3:04:57 PM GMT+8

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.
NameTitlePayExercisedYear Born
Mr. Fujun Wang GM & Non-Independent Director -- -- 1968
Mr. Jiaying Wang Financial Director & Accounting Supervisor -- -- 1982
Ms. Feifei Ma Secretary of the Board -- -- 1980
Mr. Changfeng Long Chief Engineer & Deputy GM -- -- 1975
Ms. Xiaoyan Guo Deputy General Manager -- -- 1974
Mr. Jiankang Liang Deputy General Manager -- -- 1974

Tianjin Lisheng Pharmaceutical Co.,Ltd.

No.16, Saida North 1st Road
Xiqing Eco & Tech Dev Zn
Tianjin, 300385
China
86 22 2736 4241 https://www.lishengpharma.com
Sector: 
Healthcare
Full Time Employees: 
1,328

Description

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers its products in various forms comprising tablets, soft capsules, granules, flat films, pills, mixture, and injection for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigorating qi and blood. The company also provides Chinese and Western tablets, capsules, oral liquids, granules, biological agents, and APIs. It also exports its products. The company was founded in 1951 and is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd.

Corporate Governance

Tianjin Lisheng Pharmaceutical Co.,Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

Recent Events

May 28, 2024 at 12:00 AM UTC

Ex-Dividend Date